Changes in nasal metachromatic cells during allergen immunotherapy

Area of Science:

• Allergy and Immunology
• Otorhinolaryngology

Background:

• Perennial allergic rhinitis significantly impacts quality of life.
• Allergen immunotherapy (AIT) is a treatment option for allergic rhinitis.
• The cellular mechanisms underlying AIT effectiveness require further elucidation.

Purpose of the Study:

• To investigate the impact of AIT on nasal metachromatic cell counts.
• To correlate changes in metachromatic cells with nasal symptoms and provocation responses.
• To explore the role of metachromatic cells in AIT efficacy for allergic rhinitis.

Main Methods:

• A randomized controlled study involving 25 patients with perennial allergic rhinitis.
• Two groups: AIT-treated (n=14) and control (n=11).
• Nasal symptom scores, nasal provocation tests, and metachromatic cell counts in nasal mucosal scrapings were assessed pre-treatment and at 3 and 6 months.

Main Results:

• No significant baseline differences between groups in symptoms, provocation, or cell counts.
• The AIT group showed significant reductions in nasal symptom scores and provocation responses at 3 and 6 months (P<0.05).
• A significant decrease in nasal metachromatic cell numbers was observed in the AIT group compared to baseline and the control group.

Conclusions:

• Allergen immunotherapy leads to a significant reduction in nasal metachromatic cells.
• Decreased metachromatic cell counts correlate with improved nasal allergy symptoms and reduced hypersensitivity.
• Reduction in nasal metachromatic cells is a potential mechanism explaining the therapeutic benefits of AIT in allergic rhinitis.